Oncolytics Biotech Inc T.ONC

Ever get the feeling that:

[cardu]

after waiting for something for 19 years that the answer is just around the corner?

[yureja23]

This post has been removed in accordance with Community Policy

[jimsenior]

Yes. I have no clue when, but with the recent info on hypoxia from Noteable we all have a deeper understanding. I believe we will see a collaboration of at least 3 companies. Too much at stake. This is getting very interesting.

[fox7mf]

A collaboration of at least 3 companies? How does that work when Onc has stipulated that the different indications will be packaged together for the highest bidder.? It is definitely interesting to contemplate though. 

[jimsenior]

I agree; it does seem like a stretch. I was thinking about AN today; they list as partners Roche, MSD aka Merck and ONC. Let us assume AN is not out of it.  Merck and Pfizer are together on BRACELET-1. Roche has the stellar GOBLET. Let us imagine that Roche, & Pfizer/Merck get together and take an offer to ONC. The threesome would be an entity, and they could do more for patients as an

[Noteable]

Should 3 Big Pharma companies agree to collectively acquire ONCY in a single joint partnership deal giving ONCY a US$12 Billion purchase price then I am all for it, but I think that a single Big Pharma company will step up with this offer instead.

[Noteable]

Perhaps more like a 'competition' of at least 3 companies - that we currently know of - since ONCY's Andrew de Guttadauro indicated in a recent investor conference call that both the pancreatic and breast cancer Phase 3 registration studies would be going to only one company. From de Guttadauro's comments, and those of Matt Coffey, we are led to believe that the one

[canadafan]

Money $$$ talks. Onc has stated, they want a bumdled deal. that being a partner to work through both MBc & panc cancers . However if Roche comes along with a reasonable offer , for just Panc....it will be accepted. The best way to bundle the various cancer opportunities is to buy the whole thing. Stay tuned, only 5 more trading days, until more data at the SAn Antonio symposium. I don't

[fox7mf]

If Roche tables a reasonable offer, an offer for just the pancreatic indication, it decidedly won't be accepted...we've been told as much. BP has obviously been told that all of Pela goes to the single highest bidder. It seems Oncy wants a clear concise deal (1 buyer), and nothing too messy and convoluted. 

[westcoast1000]

fox7mf, Your point is a good one, and it suggests things may go slower than might have been thought, because Roche would need to understand the whole business, not just a panc partner.

[fox7mf]

True. But the data from Goblet (panc) and Aware (breast) should provide Roche with hugely compelling reasons and justification to pull the trigger on Onc ahead of any other BP.

[Buckhenry]

so is the buyout tomorrow or the next day.............lol.... you folks seem to have it ALL figured out.... I just wished you were even half right here on the bs you post on here. 

[TitanBrawler]

There is no offer in the near future.  If the drug works it wouldn't be sitting at 2 bucks. The only thing that's real is the pumpers making everyone believe in a fairly tail. When onc hit $2.60 last week.. who do you think sold and bought back at $1.90. (I won't mention any names). These pumpers are day trading with your money and making a good living.- They have been pumping

[Lesalpes29]

m MoronBrawler is back, listen to him he knows everything about this little biotech... even what is going on behind the scene. I will keep my shares in case he is wrong! 

[Buckhenry]

you folks have been blowing smoke or smoking something fir the last 3 years. you said the same thing 3 years ago. I will just wait for official information if and when that comes. if I rubbed my crystal balls i would say we see something positive by mid 2023.